Ascendis Pharma A/S Sponsored ADRAscendis Pharma A/S Sponsored ADRAscendis Pharma A/S Sponsored ADR

Ascendis Pharma A/S Sponsored ADR

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.83 B‬USD
−4.25USD
‪−408.97 M‬USD
‪393.35 M‬USD
‪60.47 M‬
Beta (1Y)
0.56

About Ascendis Pharma A/S Sponsored ADR


CEO
Jan Møller Mikkelsen
Headquarters
Hellerup
Founded
2006
ISIN
US04351P1012
FIGI
BBG007R7VNC1
IPO date
Jan 28, 2015
IPO offer price
18.00USD
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Check out other big names from the same industry as ASND.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
IBB
iShares Biotechnology ETF
Weight
0.74%
Market value
‪65.73 M‬
USD
CGGR
Capital Group Growth ETF
Weight
0.22%
Market value
‪39.14 M‬
USD
DBXW
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 1C
Weight
0.11%
Market value
‪11.81 M‬
USD
XWEH
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 4C
Weight
0.11%
Market value
‪11.81 M‬
USD
XWD1
Xtrackers MSCI World Swap UCITS ETF
Weight
0.11%
Market value
‪11.81 M‬
USD
FDG
American Century Focused Dynamic Growth ETF
Weight
2.80%
Market value
‪9.89 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
1.00%
Market value
‪8.30 M‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
1.00%
Market value
‪8.30 M‬
USD
SPDW
SPDR Portfolio Developed World ex-US ETF
Weight
0.02%
Market value
‪7.96 M‬
USD
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
Weight
1.20%
Market value
‪7.69 M‬
USD

Explore more ETFs